申请人:Eli Lilly and Company
公开号:US05578634A1
公开(公告)日:1996-11-26
A class of novel 1H-indole-3-acetic acid hydrazides is disclosed together with the use of such indole compounds for inhibiting sPLA.sub.2 mediated release of fatty acids (e.g., arachidonic acid) for treatment of conditions such as septic shock.
一类新型的1H-吲哚-3-乙酸肼类化合物被揭示,以及利用这类吲哚化合物抑制sPLA.sub.2介导的脂肪酸(例如花生四烯酸)释放,用于治疗诸如感染性休克等疾病。